MedTrace Logo

Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

NCT05629065 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2025-08-28

No results posted yet for this study

Summary

The purpose of this study is to increase serious illness conversations (SICs) about patients goals and preferences regarding their healthcare between patients with cancer and their oncology clinicians and improved care provided near the end of life.

Conditions

Interventions

OTHER

Clinician Nudge Email

-Clinician "nudge" email encouraging discussion to initiate discussion on SIC at next visit

OTHER

Patient Nudge Letter and Share questionaire

Involves patient nudge consists of a letter and SHARE questionnaire \- patient nudge is a letter and a SHARE questionnaire encourages the participant to complete the SHARE questionnaire, which asks questions about the participants goals and preferences around cancer care, and discuss the questionnaire with their oncology clinician at the next visit.

Sponsors & Collaborators

Principal Investigators

  • Christopher Manz, MD · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-28
Primary Completion
2024-09-30
Completion
2028-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05629065 on ClinicalTrials.gov